Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shandong Weigao Orthopaedic Device Co EV-to-EBITDA?
Shandong Weigao Orthopaedic Device CoSHSE:688161 -0.65%70 EV-to-EBITDA is 23.22 as of Sep. 14, 2026, which is 25% below its 10-year median of 31.12. GuruFocus rates SHSE:688161 with a GF Score™ of 70/100 and a GF Value™ of ¥31.70 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 516 Medical Devices & Instruments companies, Shandong Weigao Orthopaedic Device Co ranks worse than 72.09% on this metric.
SHSE:688161'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 17.28 Med: 31.12 Max: 105.48
Current: 23.22
During the past 9 years, the highest EV-to-EBITDA of Shandong Weigao Orthopaedic Device Co was 105.48. The lowest was 17.28. And the median was 31.12.
SHSE:688161's EV-to-EBITDA is ranked worse than 72.09% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 13.68
vs SHSE:688161: 23.22
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shandong Weigao Orthopaedic Device Co's PE Ratio (TTM) for today is calculated as:
Shandong Weigao Orthopaedic Device Co's share price for today is ¥21.51.
Shandong Weigao Orthopaedic Device Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.650.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co EV-to-EBITDA Chart
SHSE:688161 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Shandong Weigao Orthopaedic Device Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Orthopaedic Device Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Orthopaedic Device Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Orthopaedic Device Co's EV-to-EBITDA falls into.
Shandong Weigao Orthopaedic Device Co's current Enterprise Value is ¥7,199 Mil.
Shandong Weigao Orthopaedic Device Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥310 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Orthopaedic Device Co (SHSE:688161) has a EV-to-EBITDA of 23.22 as of Sep. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shandong Weigao Orthopaedic Device Co. This is 25% below median its historical median of 31.12. Over the past decade, Shandong Weigao Orthopaedic Device Co's EV-to-EBITDA has ranged from 17.28 to 105.48. According to the industry distribution chart, Shandong Weigao Orthopaedic Device Co ranks #372 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 72.1%.
Is Shandong Weigao Orthopaedic Device Co's EV-to-EBITDA too high?
Shandong Weigao Orthopaedic Device Co's current EV-to-EBITDA of 23.22 is 25% below median its 10-year median of 31.12. Over the past 10 years, this metric has ranged from a low of 17.28 to a high of 105.48. The Medical Devices & Instruments industry median EV-to-EBITDA is 13.68. Shandong Weigao Orthopaedic Device Co's value of 23.22 is 69.7% above this industry median. Based on the distribution chart, Shandong Weigao Orthopaedic Device Co ranks #372 out of 516 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shandong Weigao Orthopaedic Device Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Orthopaedic Device Co's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Orthopaedic Device Co ranks #372 out of 516 companies for EV-to-EBITDA. This places Shandong Weigao Orthopaedic Device Co in the lower half of its industry. The industry median EV-to-EBITDA is 13.68. Shandong Weigao Orthopaedic Device Co's value of 23.22 is 69.7% above this benchmark. Historically, Shandong Weigao Orthopaedic Device Co's own EV-to-EBITDA has ranged from 17.28 to 105.48 over the past decade. While the company's 10-year median is 31.12 vs. the industry median of 13.68, Shandong Weigao Orthopaedic Device Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.68, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Orthopaedic Device Co's current EV-to-EBITDA of 23.22 is 69.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shandong Weigao Orthopaedic Device Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Orthopaedic Device Co's current EV-to-EBITDA is 23.22, which is 25% below median its own 10-year median of 31.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Orthopaedic Device Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co (SHSE:688161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥31.70, compared to a current price of ¥21.51 — trading 32.1% below its estimated fair value. The current EV-to-EBITDA is 23.22, which is 25% below median its 10-year median of 31.12 and 69.7% above the Medical Devices & Instruments industry median of 13.68. Shandong Weigao Orthopaedic Device Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Shandong Weigao Orthopaedic Device Co (SHSE:688161), the current EV-to-EBITDA is 23.22 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Orthopaedic Device Co (SHSE:688161) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Orthopaedic Device Co stock appears to be undervalued.
The current stock price of ¥21.51 is trading 32.1% below its estimated GF Value™ of ¥31.70.
GuruFocus considers Shandong Weigao Orthopaedic Device Co to be Significantly Undervalued.
Key valuation signals for SHSE:688161:
EV-to-EBITDA: 23.22 (25% below median its 10-year median of 31.12)
GF Value™: ¥31.70 vs. price of ¥21.51 (32.1% below fair value)
Industry Position: 69.7% above the Medical Devices & Instruments median (#372 of 516)
No single metric tells the full story. See the SHSE:688161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688161 has been successfully added to your 
